Literature DB >> 26362561

Effects of Running on Chronic Diseases and Cardiovascular and All-Cause Mortality.

Carl J Lavie1, Duck-chul Lee2, Xuemei Sui3, Ross Arena4, James H O'Keefe5, Timothy S Church6, Richard V Milani7, Steven N Blair3.   

Abstract

Considerable evidence has established the link between high levels of physical activity (PA) and all-cause and cardiovascular disease (CVD)-specific mortality. Running is a popular form of vigorous PA that has been associated with better overall survival, but there is debate about the dose-response relationship between running and CVD and all-cause survival. In this review, we specifically reviewed studies published in PubMed since 2000 that included at least 500 runners and 5-year follow-up so as to analyze the relationship between vigorous aerobic PA, specifically running, and major health consequences, especially CVD and all-cause mortality. We also made recommendations on the optimal dose of running associated with protection against CVD and premature mortality, as well as briefly discuss the potential cardiotoxicity of a high dose of aerobic exercise, including running (eg, marathons).
Copyright © 2015 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26362561     DOI: 10.1016/j.mayocp.2015.08.001

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  24 in total

1.  Endurance Exercise and the Heart: Friend or Foe?

Authors:  Fabian Sanchis-Gomar; Laura M Pérez; Michael J Joyner; Herbert Löllgen; Alejandro Lucia
Journal:  Sports Med       Date:  2016-04       Impact factor: 11.136

Review 2.  Novel approaches for the promotion of physical activity and exercise for prevention and management of type 2 diabetes.

Authors:  R Arena; M Sagner; N M Byrne; A D Williams; A McNeil; S J Street; A P Hills
Journal:  Eur J Clin Nutr       Date:  2017-04-26       Impact factor: 4.016

3.  The Goldilocks Zone for Exercise: Not Too Little, Not Too Much.

Authors:  James H O'Keefe; Evan L O'Keefe; Carl J Lavie
Journal:  Mo Med       Date:  2018 Mar-Apr

Review 4.  The Exercise Rehabilitation Paradox: Less May Be More?

Authors:  Parham Parto; James H O'Keefe; Carl J Lavie
Journal:  Ochsner J       Date:  2016

5.  Leisure-Time Running Reduces the Risk of Incident Type 2 Diabetes.

Authors:  Yuehan Wang; Duck-Chul Lee; Angelique G Brellenthin; Thijs M H Eijsvogels; Xuemei Sui; Timothy S Church; Carl J Lavie; Steven N Blair
Journal:  Am J Med       Date:  2019-05-17       Impact factor: 4.965

6.  Behavioral primary prevention of cardiovascular diseases.

Authors:  Andrew Elagizi; Edward Archer; Carl J Lavie
Journal:  Hepatobiliary Surg Nutr       Date:  2018-02       Impact factor: 7.293

Review 7.  Role of Inactivity in Chronic Diseases: Evolutionary Insight and Pathophysiological Mechanisms.

Authors:  Frank W Booth; Christian K Roberts; John P Thyfault; Gregory N Ruegsegger; Ryan G Toedebusch
Journal:  Physiol Rev       Date:  2017-10-01       Impact factor: 37.312

Review 8.  Running to Lower Resting Blood Pressure: A Systematic Review and Meta-analysis.

Authors:  Yutaka Igarashi; Yoshie Nogami
Journal:  Sports Med       Date:  2020-03       Impact factor: 11.136

9.  Association of All-Cause and Cardiovascular Mortality With High Levels of Physical Activity and Concurrent Coronary Artery Calcification.

Authors:  Laura F DeFina; Nina B Radford; Carolyn E Barlow; Benjamin L Willis; David Leonard; William L Haskell; Stephen W Farrell; Andjelka Pavlovic; Katelyn Abel; Jarett D Berry; Amit Khera; Benjamin D Levine
Journal:  JAMA Cardiol       Date:  2019-02-01       Impact factor: 14.676

10.  Keep on running - a randomized controlled trial to test a digital evidence-based intervention for sustained adoption of recreational running: rationale, design and pilot feasibility study.

Authors:  Hugo V Pereira; Pedro J Teixeira; Marta M Marques; Eliana V Carraça; Marlene N Silva; Jorge Encantado; Inês Santos; António L Palmeira
Journal:  Health Psychol Behav Med       Date:  2021-03-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.